Skip to content

Monitoring of the IOP After SLT Using iCare Home

Monitoring of the Intraocular Pressure After Selective Laser Trabeculoplasty Using iCare Home

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03310788
Enrollment
60
Registered
2017-10-16
Start date
2017-10-03
Completion date
2022-12-20
Last updated
2021-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma Open-Angle Primary, Pseudo Exfoliation Syndrome

Keywords

IOP fluctuations, iCare Home, SLT, self-tonometry

Brief summary

The purpose of this study is to investigate how much selective trabeculoplasty (SLT) influences intraocular pressure (IOP) fluctuations measured with iCare Home rebound tonometry (RTHome) in patients with primary open-angle glaucoma (POAG) or pseudo-exfoliation glaucoma (PEX).

Detailed description

Sixty glaucoma patients (POAG and PEX) planned for SLT will be recruited. At baseline, patients will be trained to use the iCare Home tonometer, a handheld device based on rebound tonometry and designed for patients to use at home. After the training session and when patients feel confident, a measurement will be recorded. Thereafter, a new measurement will be obtained by the study staff (an optometrist or a nurse) using the same device. No IOP values will be visible for the examiner at that point. Thereafter, a single IOP measurement will be obtained by the same study staff using Goldmann applanation tonometry (GAT). Patients will then borrow the iCare Home tonometer to meaure their IOP at 06 and 10 am, and at 2, 6 and 10 pm during three consecutive days to obtain an IOP curve. Patients will come for a second visit where new measurements will be made in the same way as at baseline. Two months after SLT, a new IOP curve will be obtained following the same procedure as pre-operatively. Patients' daily activities (diet, motion or sleeping habits) will not be controlled.

Interventions

None listed

Sponsors

St. Erik Eye Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* POAG * PXG

Exclusion criteria

* previous SLT * reduced hand and arm mobility (e.g. due to rheumatism)

Design outcomes

Primary

MeasureTime frameDescription
Lowering of IOP fluctuations after SLT2 monthsThe amplitude of the IOP fluctuations pre- and post SLT will be compared

Secondary

MeasureTime frameDescription
Lowering of IOP level after SLT2 monthsMean IOP pre- and post SLT

Countries

Sweden

Contacts

Primary ContactEnping Chen, MD PhD
enping.chen@sll.se004686720000
Backup ContactLaurence Quérat, M Sc
laurence.querat@sll.se004686723240

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026